» Articles » PMID: 32325421

Increased Expression of CD8 Marker on T-cells in COVID-19 Patients

Overview
Specialty Hematology
Date 2020 Apr 24
PMID 32325421
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cell-mediated immunity including T-cells (T helper and cytotoxic) plays an essential role in efficient antiviral responses against coronavirus disease-2019 (COVID-19). Therefore, in this study, we evaluated the ratio and expression of CD4 and CD8 markers in COVID-19 patients to clarify the immune characterizations of CD4 and CD8 T-cells in COVID-19 patients.

Methods: Peripheral blood samples of 25 COVID-19 patients and 25 normal individuals with similar age and sex as the control group were collected. White blood cells, platelets, and lymphocytes were counted and CD4 and CD8 T lymphocytes were evaluated by flow cytometry.

Results: The number of white blood cells, lymphocytes, and platelets were reduced significantly in COVID-19 patients (P < 0.05). The difference in CD4:CD8 ratio, CD4 T-cell frequency, CD8 T-cell frequency, and CD4 mean fluorescence intensity (MFI) was not significant between COVID-19 patients and healthy individuals (P > 0.05); however, the CD8 MFI increased significantly in COVID-19 infected patients (P < 0.05).

Conclusion: Although, there is no significant difference in the ratio of CD4 to CD8 between two groups, the expression level of CD8 in COVID-19 patients was significantly higher than the normal individuals. This result suggested that the cellular immune responses triggered by COVID-19 infection were developed through overexpression of CD8 and hyperactivation of cytotoxic T lymphocytes.

Citing Articles

Association of COVID-19 with thyroid dysfunction and autoimmune thyroid disease: A retrospective cohort study.

Di J, Ma X, Wu T, Qiao E, Salouti M, Zhong Y J Transl Autoimmun. 2024; 9:100255.

PMID: 39524116 PMC: 11550720. DOI: 10.1016/j.jtauto.2024.100255.


Pathophysiological, immunological, and inflammatory features of long COVID.

Bohmwald K, Diethelm-Varela B, Rodriguez-Guilarte L, Rivera T, Riedel C, Gonzalez P Front Immunol. 2024; 15:1341600.

PMID: 38482000 PMC: 10932978. DOI: 10.3389/fimmu.2024.1341600.


Effects of metformin therapy on HMGB1 levels in rheumatoid arthritis patients.

Zhang L, Zhou Y, Jiang S, Fan Y, Huang J, Xiao B Eur J Med Res. 2023; 28(1):512.

PMID: 37964313 PMC: 10648365. DOI: 10.1186/s40001-023-01476-x.


Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients.

Ramon-Luing L, Flores-Gonzalez J, Angel Garcia-Rojas L, Islas-Munoz B, Volkow-Fernandez P, Chavez-Galan L Clin Exp Immunol. 2023; 215(2):190-201.

PMID: 37904542 PMC: 10847826. DOI: 10.1093/cei/uxad115.


Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.

Shama , Mahmood A, Mehmood S, Zhang W Curr Issues Mol Biol. 2023; 45(9):7161-7182.

PMID: 37754237 PMC: 10528388. DOI: 10.3390/cimb45090453.


References
1.
McBride J, Striker R . Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?. PLoS Pathog. 2017; 13(11):e1006624. PMC: 5667733. DOI: 10.1371/journal.ppat.1006624. View

2.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

3.
Lippi G, Plebani M, Henry B . Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020; 506:145-148. PMC: 7102663. DOI: 10.1016/j.cca.2020.03.022. View

4.
Jung M, Pape G . Immunology of hepatitis B infection. Lancet Infect Dis. 2002; 2(1):43-50. DOI: 10.1016/s1473-3099(01)00172-4. View

5.
Hu B, Zeng L, Yang X, Ge X, Zhang W, Li B . Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 2017; 13(11):e1006698. PMC: 5708621. DOI: 10.1371/journal.ppat.1006698. View